Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes

International scoring system for evaluating prognosis in myelodysplastic syndromes

Greenberg, P., Cox, C., LeBeau, M. M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., et al. (1997) · Blood · doi:10.1182/blood.v89.6.2079 · Cited by 4,427 · see citing works

Regulation of ferritin genes and protein

Torti, F. M., & Torti, S. V. (2002) · Blood · doi:10.1182/blood.v99.10.3505 · Cited by 1,173 · see citing works

Cytochrome c release from mitochondria proceeds by a two-step process

Ott, M., Robertson, J. D., Gogvadze, V. G., Zhivotovsky, B., & Orrenius, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241655498 · Cited by 955 · see citing works

The genetics and pathology of oxidative phosphorylation

Smeitink, J. A. M., van den Heuvel, L., & DiMauro, S. (2001) · Nature Reviews Genetics · doi:10.1038/35072063 · Cited by 718 · see citing works

Transcriptional regulation of erythropoiesis: an affair involving multiple partners

Cantor, A. B., & Orkin, S. H. (2002) · Oncogene · doi:10.1038/sj.onc.1205326 · Cited by 584 · see citing works

Ferritin, iron homeostasis, and oxidative damage1,2 1Guest Editor: Mario Comporti 2This article is part of a series of reviews on “Iron and Cellular Redox Status.” The full list of papers may be found on the homepage of the journal.

Arosio, P., & Levi, S. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00842-0 · Cited by 543 · see citing works

Global regulation of erythroid gene expression by transcription factor GATA-1

Welch, J. J. (2004) · Blood · doi:10.1182/blood-2004-04-1603 · Cited by 408 · see citing works

The Mitochondrion in Cell Death Control: Certainties and Incognita

Loeffler, M. W., & Kroemer, G. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4833 · Cited by 394 · see citing works

Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1

Maria, R. D., Zeuner, A., Eramo, A., Domenichelli, C., Bonci, D., Grignani, F., Srinivasula, S. M., Alnemri, E. S., Testa, U., & Peschle, C. (1999) · Nature · doi:10.1038/46809 · Cited by 390 · see citing works

Injected cytochrome c induces apoptosis

Zhivotovsky, B., Orrenius, S., Brustugun, O. T., & Døskeland, S. O. (1998) · Nature · doi:10.1038/35060 · Cited by 351 · see citing works

Treatment of Anemia in Myelodysplastic Syndromes With Granulocyte Colony-Stimulating Factor Plus Erythropoietin: Results From a Randomized Phase II Study and Long-Term Follow-Up of 71 Patients

Hellström-Lindberg, E., Ahlgren, T., Beguin, Y. P., Carlsson, M., Carneskog, J., Dahl, I. M. S., Dybedal, I., Grimfors, G., Kanter‐Lewensohn, L. R., Linder, O., et al. (1998) · Blood · doi:10.1182/blood.v92.1.68.413k23_68_75 · Cited by 303 · see citing works

Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: A general mechanism to accumulate effector cells in inflammation

Dibbert, B., Weber, M., Nikolaizik, W. H., Vogt, P., Schöni, M. H., Blaser, K., & Simon, H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13330 · Cited by 278 · see citing works

Apoptotic mechanisms in the control of erythropoiesis

Testa, U. (2004) · Leukemia · doi:10.1038/sj.leu.2403383 · Cited by 226 · see citing works

Early Mitochondrial Activation and Cytochrome c Up-regulation during Apoptosis

Chandra, D., Liu, J.-W., & Tang, D. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207622200 · Cited by 217 · see citing works

GATA-1 converts lymphoid and myelomonocytic progenitors into the megakaryocyte/erythrocyte lineages.

Iwasaki, H., Mizuno, S., Wells, R., Cantor, A., Watanabe, S., & Akashi, K. (2003) · Immunity · doi:10.1016/s1074-7613(03)00242-5 · Cited by 214 · see citing works

Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?

Barrett, J., Saunthararajah, Y., & Molldrem, J. (2000) · Seminars in Hematology · doi:10.1016/s0037-1963(00)90027-1 · Cited by 207 · see citing works

Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia

Cazzola, M., Invernizzi, R., Bergamaschi, G., Levi, S., Corsi, B., Travaglino, E., Rolandi, V., Biasiotto, G., Drysdale, J., & Arosio, P. (2003) · Blood · doi:10.1182/blood-2002-07-2006 · Cited by 205 · see citing works

Hematopoietic development: a balancing act

Cantor, A. B., & Orkin, S. H. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00226-4 · Cited by 191 · see citing works

Mitochondrial Ferritin: A New Player in Iron Metabolism

Drysdale, J., Arosio, P., Invernizzi, R., Cazzola, M., Volz, A., Corsi, B., Biasiotto, G., & Levi, S. (2002) · Blood Cells, Molecules, and Diseases · doi:10.1006/bcmd.2002.0577 · Cited by 180 · see citing works

Overexpression of mitochondrial ferritin causes cytosolic iron depletion and changes cellular iron homeostasis

Nie, G., Sheftel, A. D., Kim, S. F., & Ponka, P. (2004) · Blood · doi:10.1182/blood-2004-07-2722 · Cited by 179 · see citing works

Identification of myelodysplastic syndrome–specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction

Miyazato, A., Ueno, S., Ohmine, K., Ueda, M., Yoshida, K., Yamashita, Y., Kaneko, T., Mori, M., Kirito, K., Toshima, M., et al. (2001) · Blood · doi:10.1182/blood.v98.2.422 · Cited by 170 · see citing works

Pathogenesis, etiology and epidemiology of myelodysplastic syndromes.

Aul, C., Bowen, D. T., & Yoshida, Y. (1998) · PubMed · Cited by 167 · see citing works

Granulocyte colony-stimulating factor inhibits the mitochondria-dependent activation of caspase-3 in neutrophils

Mayanskiy, N. A., Mul, E. P. J., van Buul, J. D., Roos, D., & Kuijpers, T. W. (2002) · Blood · doi:10.1182/blood.v99.2.672 · Cited by 165 · see citing works

Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte‐mediated inhibition of CFU‐GM and alterations in T‐cell receptor Vβ profiles

Molldrem, J. J., Jiang, Y. Z., Stetler‐Stevenson, M., Mavroudis, D., Hensel, N. F., & Barrett, A. J. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00920.x · Cited by 160 · see citing works

Measurement of ATP production and respiratory chain enzyme activities in mitochondria isolated from small muscle biopsy samples

Wibom, R., Hagenfeldt, L., & von Döbeln, U. (2002) · Analytical Biochemistry · doi:10.1016/s0003-2697(02)00424-4 · Cited by 148 · see citing works

Hypocellular myelodysplastic syndromes (MDS): new proposals

Tüzüner, N., Cox, C., Rowe, J. M., Watrous, D., & Bennett, J. M. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05356.x · Cited by 143 · see citing works

GATA-1 transactivates erythropoietin receptor gene, and erythropoietin receptor-mediated signals enhance GATA-1 gene expression

Chiba, T., Ikawa, Y., & Todokoro, K. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.14.3843 · Cited by 143 · see citing works

Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors

Tehranchi, R., Fadeel, B., Forsblom, A., Christensson, B., Samuelsson, J., Zhivotovsky, B., & Hellström‐Lindberg, E. (2003) · Blood · doi:10.1182/blood-2002-06-1774 · Cited by 130 · see citing works

‘Low‐risk’ myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro‐ versus anti‐apoptotic bcl‐2‐related proteins

Parker, Fishlock, Mijovic, Czepulkowski, Pagliuca, A., & Mufti (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.01114.x · Cited by 118 · see citing works

Bid Truncation, Bid/Bax Targeting to the Mitochondria, and Caspase Activation Associated with Neutrophil Apoptosis Are Inhibited by Granulocyte Colony-Stimulating Factor

Mayanskiy, N. A., Roos, D., & Kuijpers, T. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.7024 · Cited by 81 · see citing works

Erythropoietin receptor signals both proliferation and erythroid-specific differentiation.

Liboi, E., Carroll, M. P., D’Andrea, A. D., & Mathey-Prévôt, B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11351 · Cited by 77 · see citing works

Role of iron and ferritin in TNFα‐induced apoptosis in HeLa cells

Cozzi, A., Levi, S., Corsi, B., Santambrogio, P., Campanella, A., Gerardi, G., & Arosio, P. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00114-5 · Cited by 76 · see citing works

Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transduction

Fontenay, M., Bouscary, D., Guesnu, M., Picard, F., Melle, J., Lacombe, C., Gisselbrecht, S., Mayeux, P., & Dreyfus, F. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01539.x · Cited by 74 · see citing works

Apoptosis in refractory anaemia with ringed sideroblasts is initiated at the stem cell level and associated with increased activation of caspases

Lindberg, E. H., Schmidt‐Mende, J., Forsblom, A., Christensson, B., Fadeel, B., & Zhivotovsky, B. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02581.x · Cited by 62 · see citing works

Refractory myelodysplastic anaemias with hypocellular bone marrow.

Yoshida, Y., Oguma, S., Uchino, H., & MAEKAWA, T. (1988) · Journal of Clinical Pathology · doi:10.1136/jcp.41.7.763 · Cited by 61 · see citing works

Increased apoptosis in acquired sideroblastic anaemia

Matthes, T., Meyer, G., Samii, K., & Beris, P. (2000) · British Journal of Haematology · doi:10.1111/j.1365-2141.2000.02425.x · Cited by 41 · see citing works

In vitro expansion of human cord blood CD36+ erythroid progenitors: Temporal changes in gene and protein expression

Scicchitano, M. S., McFarland, D. C., Tierney, L. A., Narayanan, P. K., & Schwartz, L. W. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00185-1 · Cited by 38 · see citing works

Granulocyte colony-stimulating factor inhibits Fas-triggered apoptosis in bone marrow cells isolated from patients with refractory anemia with ringed sideroblasts

Schmidt-Mende, J., Tehranchi, R., Forsblom, A., Joseph, B., Christensson, B., Fadeel, B., Zhivotovsky, B., & Hellström‐Lindberg, E. (2001) · Leukemia · doi:10.1038/sj.leu.2402110 · Cited by 37 · see citing works

Erythropoiesis in myelodysplastic syndrome: expression of receptors for erythropoietin and kit ligand.

Backx, B., Broeders, L., Lh, H., Wognum, B., & Löwenberg, B. (1996) · PubMed · Cited by 35 · see citing works

Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.

Toyama, K., Ohyashiki, K., Yoshida, Y., Abe, T., Asano, S., Hirai, H., Hirashima, K., Hotta, T., Kuramoto, A., & Kuriya, S. (1993) · PubMed · Cited by 33 · see citing works

Hypochromic red blood cells in low-risk myelodysplastic syndromes: effects of treatment with hemopoietic growth factors.

Ljung, T., Bäck, R., & Hellström‐Lindberg, E. (2004) · PubMed · Cited by 18 · see citing works

Differentiation kinetics and globin gene expression by circulating human BFUe in suspension cultures.

Umemura, T., Constantoulakis, P., Papayannopoulou, T., & Stamatoyannopoulos, G. (1990) · PubMed · Cited by 7 · see citing works

Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts

Papaemmanuil, E., Cazzola, M., Boultwood, J., Malcovati, L., Vyas, P., Bowen, D., Pellagatti, A., Wainscoat, J. S., Hellstrom-Lindberg, E., Gambacorti-Passerini, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103283 · Cited by 1,222 · see citing works

Ferritins: A family of molecules for iron storage, antioxidation and more

Arosio, P., Ingrassia, R., & Cavadini, P. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.09.004 · Cited by 886 · see citing works

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

Fenaux, P., Platzbecker, U., Mufti, G. J., Garcia‐Manero, G., Buckstein, R. J., Santini, V., Díez‐Campelo, M., Finelli, C., Cazzola, M., İlhan, O., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1908892 · Cited by 551 · see citing works

Intracellular iron transport and storage: from molecular mechanisms to health implications

Mackenzie, E. L., Iwasaki, K., & Tsuji, Y. (2008) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2007.1893 · Cited by 526 · see citing works

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

Malcovati, L., Papaemmanuil, E., Bowen, D., Boultwood, J., Porta, M. G. D., Pascutto, C., Travaglino, E., Groves, M. J., Godfrey, A. L., Ambaglio, I., et al. (2011) · Blood · doi:10.1182/blood-2011-09-377275 · Cited by 496 · see citing works

Myelodysplastic syndromes

Adès, L., Itzykson, R., & Fenaux, P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61901-7 · Cited by 396 · see citing works

Myelodysplastic syndromes: the complexity of stem-cell diseases

Corey, S. J., Minden, M. D., Barber, D. L., Kantarjian, H. M., Wang, J. C. Y., & Schimmer, A. D. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2047 · Cited by 341 · see citing works

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells

Pellagatti, A., Cazzola, M., Giagounidis, A. A. N., Perry, J., Malcovati, L., Porta, M. G. D., Jädersten, M., Killick, S. B., Verma, A. K., Norbury, C. J., et al. (2010) · Leukemia · doi:10.1038/leu.2010.31 · Cited by 288 · see citing works

Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders

Hexner, E. O., Serdikoff, C., Jan, M., Swider, C. R., Robinson, C., Yang, S., Angeles, T. S., Emerson, S. G., Carroll, M. P., Ruggeri, B., et al. (2007) · Blood · doi:10.1182/blood-2007-04-083402 · Cited by 253 · see citing works

The Myelodysplastic Syndromes: Diagnosis and Treatment

Steensma, D. P., & Bennett, J. M. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.1.104 · Cited by 242 · see citing works

Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations

Pellagatti, A., Armstrong, R. N., Steeples, V., Sharma, E., Repapi, E., Singh, S., Sanchi, A., Radujkovic, A., Horn, P., Dolatshad, H., et al. (2018) · Blood · doi:10.1182/blood-2018-04-843771 · Cited by 240 · see citing works

Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q− syndrome patients

Pellagatti, A., Jädersten, M., Forsblom, A., Cattan, H., Christensson, B., Emanuelsson, E. K., Merup, M., Nilsson, L., Samuelsson, J., Sander, B., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610477104 · Cited by 232 · see citing works

SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts

Visconte, V., Makishima, H., Jankowska, A. M., Szpurka, H., Traina, F., Jerez, A., O'Keefe, C., Rogers, H. J., Sekeres, M. A., Maciejewski, J. P., et al. (2011) · Leukemia · doi:10.1038/leu.2011.232 · Cited by 212 · see citing works

Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia

Shiozawa, Y., Malcovati, L., Gallì, A., Sato‐Otsubo, A., Kataoka, K., Sato, Y., Watatani, Y., Suzuki, H., Yoshizato, T., Yoshida, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06063-x · Cited by 172 · see citing works

Mitochondrial Ferritin Expression in Adult Mouse Tissues

Santambrogio, P., Biasiotto, G., Sanvito, F., Olivieri, S., Arosio, P., & Levi, S. (2007) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.7a7273.2007 · Cited by 169 · see citing works

RNA silencing of the mitochondrial ABCB7 transporter in HeLa cells causes an iron-deficient phenotype with mitochondrial iron overload

Cavadini, P., Biasiotto, G., Poli, M., Levi, S., Verardi, R., Zanella, I., Derosas, M., Ingrassia, R., Corrado, M., & Arosio, P. (2006) · Blood · doi:10.1182/blood-2006-08-041632 · Cited by 155 · see citing works

Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms

Cazzola, M., Rossi, M., & Malcovati, L. (2012) · Blood · doi:10.1182/blood-2012-09-399725 · Cited by 151 · see citing works

Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome

Porta, M. G. D., Malcovati, L., Invernizzi, R., Travaglino, E., Pascutto, C., Maffioli, M., Gallì, A., Boggi, S., Pietra, D., Vanelli, L., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404142 · Cited by 137 · see citing works

Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndrome

Ghoti, H., Amer, J., Winder, A., Rachmilewitz, E. A., & Fibach, E. (2007) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2007.00972.x · Cited by 110 · see citing works

Clinical Relevance of Anemia and Transfusion Iron Overload in Myelodysplastic Syndromes

Cazzola, M., Porta, M. G. D., & Malcovati, L. (2008) · Hematology · doi:10.1182/asheducation-2008.1.166 · Cited by 101 · see citing works

The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts

Nikpour, M., Scharenberg, C., Liu, A., Conte, S., Karimi, M., Blanco, T. M., Giai, V., Fernández‐Mercado, M., Papaemmanuil, E., Högstrand, K., et al. (2012) · Leukemia · doi:10.1038/leu.2012.298 · Cited by 99 · see citing works

Abnormal erythropoiesis and the pathophysiology of chronic anemia

Koury, M. J. (2014) · Blood Reviews · doi:10.1016/j.blre.2014.01.002 · Cited by 96 · see citing works

Haploinsufficiency of RPS14 in 5q− syndrome is associated with deregulation of ribosomal‐ and translation‐related genes

Pellagatti, A., Hellström‐Lindberg, E., Giagounidis, A. A. N., Perry, J., Malcovati, L., Porta, M. G. D., Jädersten, M., Killick, S. B., Fidler, C., Cazzola, M., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07178.x · Cited by 92 · see citing works

A variant erythroferrone disrupts iron homeostasis in <i>SF3B1</i> -mutated myelodysplastic syndrome

Bondu, S., Alary, A.-S., Lefèvre, C., Houy, A., Jung, G., Lefebvre, T., Rombaut, D., Boussaid, I., Bousta, A., Guillonneau, F., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav5467 · Cited by 85 · see citing works

Recent advances in the understanding of inherited sideroblastic anaemia

Camaschella, C. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07290.x · Cited by 77 · see citing works

The bone marrow hematopoietic microenvironment is impaired in iron‐overloaded mice

Okabe, H., Suzuki, T., Uehara, E., Ueda, M., Nagai, T., & Ozawa, K. (2014) · European Journal Of Haematology · doi:10.1111/ejh.12309 · Cited by 75 · see citing works

Targeting autophagy to fight hematopoietic malignancies

Puissant, A., Robert, G., & Auberger, P. (2010) · Cell Cycle · doi:10.4161/cc.9.17.13048 · Cited by 71 · see citing works

Defective nuclear localization of Hsp70 is associated with dyserythropoiesis and GATA-1 cleavage in myelodysplastic syndromes

Frisan, E., Vandekerckhove, J., de Thonel, A., Pierre‐Eugène, C., Sternberg, A. J., Arlet, J., Floquet, C., Gyan, E., Kosmider, O., Dreyfus, F., et al. (2011) · Blood · doi:10.1182/blood-2011-03-343475 · Cited by 71 · see citing works

Ring sideroblasts and sideroblastic anemias

Cazzola, M., & Invernizzi, R. (2011) · Haematologica · doi:10.3324/haematol.2011.044628 · Cited by 71 · see citing works

Myelodysplastic syndromes: biology and treatment

Jädersten, M., & Hellström‐Lindberg, E. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02052.x · Cited by 65 · see citing works

SF3B1 mutant-induced missplicing of MAP3K7 causes anemia in myelodysplastic syndromes

Lieu, Y. K., Liu, Z., Ali, A. M., Wei, X., Penson, A., Zhang, J., An, X., Rabadán, R., Raza, A., Manley, J. L., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111703119 · Cited by 59 · see citing works

Mitochondrial Ferritin: Its Role in Physiological and Pathological Conditions

Levi, S., Ripamonti, M., Dardi, M., Cozzi, A., & Santambrogio, P. (2021) · Cells · doi:10.3390/cells10081969 · Cited by 59 · see citing works

Cytochrome c Upregulation during Capacitation and Spontaneous Acrosome Reaction Determines the Fate of Pig Sperm Cells: Linking Proteome Analysis

Choi, Y., Uhm, S. J., Song, S.-J., Song, H., Park, J.-K., Kim, T., Park, C., & Kim, J. (2008) · Journal of Reproduction and Development · doi:10.1262/jrd.19116 · Cited by 59 · see citing works

Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes

Wulfert, M., Küpper, A. C., Tapprich, C., Bottomley, S. S., Bowen, D., Germing, U., Haas, R. R., & Gattermann, N. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.01.004 · Cited by 58 · see citing works

Mice lacking mitochondrial ferritin are more sensitive to doxorubicin-mediated cardiotoxicity

Maccarinelli, F., Gammella, E., Asperti, M., Regoni, M., Biasiotto, G., Turco, E., Altruda, F., Lonardi, S., Cornaghi, L., Donetti, E., et al. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1147-0 · Cited by 56 · see citing works

In vivo tumor growth is inhibited by cytosolic iron deprivation caused by the expression of mitochondrial ferritin

Nie, G., Chen, G., Sheftel, A. D., Pantopoulos, K., & Ponka, P. (2006) · Blood · doi:10.1182/blood-2006-04-018341 · Cited by 56 · see citing works

The RNA Binding Protein RBM38 (RNPC1) Regulates Splicing during Late Erythroid Differentiation

Heinicke, L. A., Nabet, B., Shen, S., Jiang, P., van Zalen, S., Cieply, B. W., Russell, J., Xing, Y., & Carstens, R. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078031 · Cited by 51 · see citing works

Erythroid precursors from patients with low-risk myelodysplasia demonstrate ultrastructural features of enhanced autophagy of mitochondria

Houwerzijl, E. J., Pol, H.-W., Blom, N. R., van der Want, J. J. L., de Wolf, J., & Vellenga, E. (2009) · Leukemia · doi:10.1038/leu.2008.389 · Cited by 50 · see citing works

Supportive Care and Use of Hematopoietic Growth Factors in Myelodysplastic Syndromes

Hellström‐Lindberg, E., & Malcovati, L. (2008) · Seminars in Hematology · doi:10.1053/j.seminhematol.2007.10.004 · Cited by 49 · see citing works

Smad2/3‐pathway ligand trap luspatercept enhances erythroid differentiation in murine β‐thalassaemia by increasing GATA‐1 availability

Martinez, P. A., Li, R., Ramanathan, H. N., Bhasin, M., Pearsall, R. S., Kumar, R., & Suragani, R. N. V. S. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15243 · Cited by 49 · see citing works

The Role of JAK2 Mutations in RARS and Other MDS

Hellström‐Lindberg, E., & Cazzola, M. (2008) · Hematology · doi:10.1182/asheducation-2008.1.52 · Cited by 42 · see citing works

Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF 3B1mutated refractory anaemia with ring sideroblasts

Conte, S., Katayama, S., Vesterlund, L., Karimi, M., Dimitriou, M., Jansson, M., Blanco, T. M., Unneberg, P., Papaemmanuil, E., Sander, B., et al. (2015) · British Journal of Haematology · doi:10.1111/bjh.13610 · Cited by 37 · see citing works

Myelodysplastic syndrome: An inability to appropriately respond to damaged DNA?

Zhou, T., Hasty, P., Walter, C. A., Bishop, A. J. R., Scott, L. M., & Rebel, V. I. (2013) · Experimental Hematology · doi:10.1016/j.exphem.2013.04.008 · Cited by 39 · see citing works

The molecular pathogenesis of myelodysplastic syndromes

Davids, M. S., & Steensma, D. P. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.4.12612 · Cited by 40 · see citing works

Supportive care, growth factors, and new therapies in myelodysplastic syndromes

Hellström‐Lindberg, E., & Malcovati, L. (2008) · Blood Reviews · doi:10.1016/j.blre.2007.10.003 · Cited by 38 · see citing works

Gene expression profiling of erythroblasts from refractory anaemia with ring sideroblasts (RARS) and effects of G‐CSF

Nikpour, M., Pellagatti, A., Liu, A., Karimi, M., Malcovati, L., Gogvadze, V. G., Forsblom, A., Wainscoat, J. S., Cazzola, M., Zhivotovsky, B., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08174.x · Cited by 36 · see citing works

Blood-Enriching Effects and Immune-Regulation Mechanism of Steam-Processed Polygonatum Sibiricum Polysaccharide in Blood Deficiency Syndrome Mice

Wang, J., Wang, F., Yuan, L., Ruan, H., Zhu, Z., Fan, X., Zhu, L., & Peng, X. X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.813676 · Cited by 34 · see citing works

Myelodysplasia paranoia: Iron as the new radon

Steensma, D. P. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.10.017 · Cited by 34 · see citing works

Over-expression of mitochondrial ferritin affects the JAK2/STAT5 pathway in K562 cells and causes mitochondrial iron accumulation

Santambrogio, P., Erba, B. G., Campanella, A., Cozzi, A., Causarano, V., Cremonesi, L., Gallì, A., Porta, M. G. D., Invernizzi, R., & Levi, S. (2011) · Haematologica · doi:10.3324/haematol.2011.042952 · Cited by 33 · see citing works

Recent advances in the understanding of iron overload in sideroblastic myelodysplastic syndrome

Cuijpers, M. L. H., Raymakers, R. A. P., MacKenzie, M. A., de Witte, T. J. M., & Swinkels, D. W. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.08051.x · Cited by 32 · see citing works

Update on Supportive Care and New Therapies: Immunomodulatory Drugs, Growth Factors and Epigenetic-Acting Agents

Hellström‐Lindberg, E. (2005) · Hematology · doi:10.1182/asheducation-2005.1.161 · Cited by 31 · see citing works

Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in SF3B1 -mutated myelodysplasia

Mian, S. A., Philippe, C., Maniati, E., Protopapa, P., Bergot, T., Piganeau, M., Nemkov, T. G., Bella, D. D., Morales, V., Finch, A. J., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abn5135 · Cited by 28 · see citing works

Overexpression of Mitochondrial Ferritin Sensitizes Cells to Oxidative Stress Via an Iron-Mediated Mechanism

Lu, Z., Nie, G., Li, Y., Soe-Lin, S., Tao, Y., Cao, Y., Zhang, Z., Liu, N., Ponka, P., & Zhao, B. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2306 · Cited by 28 · see citing works

Potential Relationship between Inadequate Response to DNA Damage and Development of Myelodysplastic Syndrome

Zhou, T., Chen, P., Gu, J. H., Bishop, A. J. R., Scott, L., Hasty, P., & Rebel, V. I. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16010966 · Cited by 26 · see citing works

Dyserythropoiesis of myelodysplastic syndromes

Lefèvre, C., Bondu, S., Goff, S. L., Kosmider, O., & Fontenay, M. (2017) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000325 · Cited by 25 · see citing works

A phase 2, randomized, double‐blind, multicenter study comparing siltuximab plus best supportive care (BSC) with placebo plus BSC in anemic patients with International Prognostic Scoring System low‐ or intermediate‐1–risk myelodysplastic syndrome

Garcia‐Manero, G., Gartenberg, G. J., Steensma, D. P., Schipperus, M. R., Breems, D. A., de Paz, R., Valcárcel, D., Kranenburg, B., Reddy, M. P., & Komrokji, R. S. (2014) · American Journal of Hematology · doi:10.1002/ajh.23780 · Cited by 24 · see citing works

Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS

Park, S., Sapena, R., Kelaïdi, C., Vassilieff, D., Bordessoule, D., Stamatoullas, A., Chèze, S., Beyne‐Rauzy, O., Vey, N., Rose, C., et al. (2011) · Leukemia Research · doi:10.1016/j.leukres.2011.07.007 · Cited by 24 · see citing works

Candidate gene mutation analysis in idiopathic acquired sideroblastic anemia (refractory anemia with ringed sideroblasts)

Steensma, D. P., Hecksel, K. A., Porcher, J. C., & Lasho, T. L. (2006) · Leukemia Research · doi:10.1016/j.leukres.2006.06.005 · Cited by 24 · see citing works

Insight into the molecular pathophysiology of myelodysplastic syndromes: targets for novel therapy

Zahid, M. F., Patnaik, M. M., Gangat, N., Hashmi, S. K., & Rizzieri, D. A. (2016) · European Journal Of Haematology · doi:10.1111/ejh.12771 · Cited by 23 · see citing works

Epigenetic dysregulation of GATA1 is involved in myelodysplastic syndromes dyserythropoiesis

Hopfer, O., Nolte, F., Mossner, M., Komor, M., Kmetsch, A., Benslasfer, O., Reißmann, M., Nowak, D., Hoelzer, D. F., Thiel, E., et al. (2011) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2011.01715.x · Cited by 23 · see citing works

A three-dimensional in vitro model of erythropoiesis recapitulates erythroid failure in myelodysplastic syndromes

Elvarsdóttir, E. M., Blanco, T. M., Dimitriou, M., Bouderlique, T., Jansson, M., Hofman, I. J., Conte, S., Karimi, M., Sander, B., Douagi, I., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0532-7 · Cited by 22 · see citing works

EDAG mediates Hsp70 nuclear localization in erythroblasts and rescues dyserythropoiesis in myelodysplastic syndrome

Dong, X., Zhao, K., Zheng, W., Xu, C., Zhang, M., Yin, R., Gao, R., Tang, L., Liu, J., Chen, H., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902946r · Cited by 16 · see citing works

Generation and Molecular Characterization of Human Ring Sideroblasts: a Key Role of Ferrous Iron in Terminal Erythroid Differentiation and Ring Sideroblast Formation

Saito, K., Fujiwara, T., Hatta, S., Morita, M., Ono, K., Suzuki, C., Fukuhara, N., Onishi, Y., Nakamura, Y., Kawamata, S., et al. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00387-18 · Cited by 15 · see citing works

Effect of iron chelator deferasirox on chronic anemia and thrombocytopenia in a transfusion-dependent patient with myelodysplastic syndrome

Nishiuchi, T., Okutani, Y., Fujita, T., Yoshida, K., Ohnishi, H., & Haba, R. (2010) · International Journal of Hematology · doi:10.1007/s12185-010-0500-5 · Cited by 15 · see citing works

AUF-1 and YB-1 are critical determinants of β-globin mRNA expression in erythroid cells

van Zalen, S., Jeschke, G. R., Hexner, E. O., & Russell, J. (2011) · Blood · doi:10.1182/blood-2011-10-387316 · Cited by 15 · see citing works

Significance of JAK2 and TET2 mutations in myelodysplastic syndromes

Hellström‐Lindberg, E. (2010) · Blood Reviews · doi:10.1016/j.blre.2010.01.002 · Cited by 14 · see citing works

Unimpaired terminal erythroid differentiation and preserved enucleation capacity in myelodysplastic 5q(del) clones: a single cell study

Garderet, L., Kobari, L., Mazurier, C., Witte, C. D., Giarratana, M., Pérot, C., Gorin, N. C., Lapillonne, H., & Douay, L. (2009) · Haematologica · doi:10.3324/haematol.2009.012773 · Cited by 12 · see citing works

Effects of mitochondrial ferritin overexpression in normal and sideroblastic erythroid progenitors

Invernizzi, R., Travaglino, E., Porta, M. G. D., Gallì, A., Malcovati, L., Rosti, V., Bergamaschi, G., Erba, B. G., Bellistri, F., Bastia, R., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12316 · Cited by 12 · see citing works

Programmed necroptosis is upregulated in low-grade myelodysplastic syndromes and may play a role in the pathogenesis

Zou, J., Shi, Q., Chen, H., Juskevicius, R., & Zinkel, S. S. (2021) · Experimental Hematology · doi:10.1016/j.exphem.2021.09.004 · Cited by 10 · see citing works

Sequence Variations in Mitochondrial Ferritin: Distribution in Healthy Controls and Different Types of Patients

Castiglioni, E., Finazzi, D., Goldwurm, S., Levi, S., Pezzoli, G., Garavaglia, B., Nardocci, N., Malcovati, L., della Porta, M. D., Gallì, A., et al. (2010) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2010.0076 · Cited by 16 · see citing works

Apoptotic pathways to death in myelodysplastic syndromes

Fontenay, M., & Gyan, E. (2008) · Haematologica · doi:10.3324/haematol.13563 · Cited by 10 · see citing works

Ringed sideroblasts in β‐thalassemia

Cattivelli, K., Campagna, D. R., Schmitz‐Abe, K., Heeney, M. M., Yaish, H. M., Brown, A. E. C., Kearney, S. L., Walkovich, K. J., Markianos, K., Fleming, M. D., et al. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.26324 · Cited by 9 · see citing works

Impact of Growth Factors in the Regulation of Apoptosis in Low-Risk Myelodysplastic Syndromes

Tehranchi, R. (2006) · Medical Oncology · doi:10.1385/mo:23:1:37 · Cited by 8 · see citing works

Splicing factor SF3B1 mutations and ring sideroblasts in myelodysplastic syndromes: a Brazilian cohort screening study

Donaires, F. S., Martelli, F., Alves-Paiva, R. D. M., Magalhães, S. M. M., Pinheiro, R. F., & Calado, R. T. (2016) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.1016/j.bjhh.2016.06.002 · Cited by 7 · see citing works

Myelodysplastic patients with raised percentage of hypochromic red cells have evidence of functional iron deficiency

Murphy, P. T., Quinn, J., O’Donghaile, D., Swords, R. T., & O’Donnell, J. R. (2006) · Annals of Hematology · doi:10.1007/s00277-006-0107-3 · Cited by 7 · see citing works

Pathophysiology of Myelodysplastic Syndromes

Fontenay, M., Farhat, B., & Boussaid, I. (2021) · Hemato · doi:10.3390/hemato2030030 · Cited by 6 · see citing works

Increased Apoptosis as a Mechanism of Ineffective Erythropoiesis in Myelodysplastic Syndromes

Invernizzi, R., & Travaglino, E. (2008) · Clinical Leukemia · doi:10.3816/clk.2008.n.014 · Cited by 6 · see citing works

SF3B1-mutant models of RNA mis-splicing uncover UBA1 as a therapeutic target in myelodysplastic neoplasms

Thier, J., Hofmann, S., Kirchhof, K. M., Todisco, G., Blanco, T. M., Lilienthal, I., Kanellis, D. C., Barbosa, I., Björklund, A.-C., Deslauriers, A. G., et al. (2025) · Leukemia · doi:10.1038/s41375-025-02740-1 · Cited by 4 · see citing works

Treatment of myelodysplastic syndromes with exogenous erythropoietin: a new therapeutic paradigm

Mundle, S. D., & Raza, A. (2006) · Leukemia · doi:10.1038/sj.leu.2404291 · Cited by 4 · see citing works

Flow Cytometry in Myelodysplastic Syndromes

Alhan, C., Westers, T. M., Ossenkoppele, G. J., & van de Loosdrecht, A. A. (2011) · Springer eBooks · doi:10.1007/978-94-007-0440-4_8 · Cited by 3 · see citing works

Erythroid progenitors from patients with low-risk myelodysplastic syndromes are dependent on the surrounding micro environment for their survival

Folkerts, H., Hazenberg, C. L. E., Houwerzijl, E. J., van den Heuvel, F. A. J., Mulder, A. B., van der Want, J. J. L., & Vellenga, E. (2014) · Experimental Hematology · doi:10.1016/j.exphem.2014.11.005 · Cited by 3 · see citing works

The Hematopoietic Growth Factors in the Myelodysplastic Syndromes

Ortega, J., Komrokji, R. S., & List, A. F. (2010) · Cancer treatment and research · doi:10.1007/978-1-4419-7073-2_20 · Cited by 3 · see citing works

Comprehensive analysis of a necroptosis-associated diagnostic signature for myelodysplastic syndromes based on single-cell RNA-seq and bulk RNA-seq

Zhang, H., Zhang, L., Liang, X., Zhang, L., Ma, B., Li, Y., Wang, J., Shen, Y., Pang, Y., & Xiong, J. (2024) · Hereditas · doi:10.1186/s41065-024-00335-x · Cited by 2 · see citing works

Physiopathologie des syndromes myélodysplasiques

Fontenay, M., Kosmider, O., Frisan, E., Ettou, S. S., & Lacombe, C. (2009) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(09)74245-5 · Cited by 1 · see citing works

Atypical ringed sideroblasts in association with trisomy 19 and myelodysplasia

Muhyieddeen, K., & Natelson, E. A. (2011) · Comparative Clinical Pathology · doi:10.1007/s00580-011-1298-0 · Cited by 1 · see citing works

Cytokines in MDS: Abnormalities and Treatment

Oster, H. S., Neumann, D., & Mittelman, M. (2011) · Springer eBooks · doi:10.1007/978-94-007-0440-4_13 · Cited by 1 · see citing works

Relationship between the Induced Iron Overload Model and Hepatic Erythropoiesis in Xenopus laevis

Sato, K., 正光, 谷., Kato, K., & Kato, T. (2020) · ZOOLOGICAL SCIENCE · doi:10.2108/zs190102 · Cited by 1 · see citing works

Recombinant human erythropoietin (rhEPO) therapy in myelodysplasia

Hellström‐Lindberg, E. (2008) · Springer eBooks · doi:10.1007/978-3-211-69459-6_20

Identification of the Genomic Breakpoints of a Novel Chromosome Translocation in Myelodysplastic Syndrome

de Matos, S. S. M. C. (2011)

myelodysplastic syndromes: pharmacodynamic, mechanistic and clinical studies

Khan, R. (2007)

DNA methylation and 5-azacytidine in myelodysplastic syndromes : Pharmacodynamic, mechanistic and clinical studies

Khan, R. (2007) · Figshare

The place of sideroblastic erythropoiesis in WHO 2008 classification of MDS; RCMD versus RCMD-RD as combined or a separate entity?

Yoshida, Y. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.04.004

Activated lymphocytes and monocytes in myelodysplastic syndromes

Meers, S. (2008)

5. Iron Overload and Bone Marrow Failure.

Yamashita, T., & Nakao, S. (2010) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.99.1261

輸血後鉄過剰症に対するICL670 (deferasirox)投与により造血能の回復が得られた骨髄異形成症候群

寛, 岡., 隆浩, 鈴., 司, 大., 政樹, 森., Uehara, E., Hatano, K., 上田, 真., 松山, 智., 外島, 正., 尾崎勝俊, et al. (2009) · 臨床血液 · doi:10.11406/rinketsu.50.1626

Myelodysplastic syndromes

Wilkins, B., & Porwit‐MacDonald, A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3147-2.00020-1

Syndromes myélodysplasiques et leucémies secondaires. Généralités, diagnostic et classification

Park, S., Cluzeau, T., Fenaux, P., & Dreyfus, F. (2014)

Erythropoiesis-Stimulating Agents in Low-Risk MDS

Park, S., & Götze, K. S. S. (2018) · Hematologic malignancies · doi:10.1007/978-3-319-76879-3_6

Modelling Ineffective Erythropoiesis in Myelodysplastic Syndromes with Ring Sideroblasts

Elvarsdóttir, E. M. (2019) · Figshare · doi:10.13140/rg.2.2.13726.28485

SF3B1 -mutant mis-splicing of UBA1 confers a targetable therapeutic vulnerability through UBA1 inhibitionPreprint

Thier, J., Hofmann, S., Kirchhof, K. M., Todisco, G., Blanco, T. M., Barbosa, I., Björklund, A.-C., Deslauriers, A. G., Papaemmanuil, E., Papapetrou, E. P., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.28.610114

Erythropoiesis Is Highly Stimulated in CD34+ Cells in Low-Risk Myelodysplastic Syndromes (MDS) with an Improper Mitochondrial Function.

Tehranchi, R., Invernizzi, R., Zhivotovsky, B., Fadeel, B., Forsblom, A., Travaglino, E., Samuelsson, J., Hast, R., Nilsson, L., Wibom, R., et al. (2004) · Blood · doi:10.1182/blood.v104.11.473.473

syndromes characterize early erythroid precursors in low-risk myelodysplastic Aberrant mitochondrial iron distribution and maturation arrest

Hellström‐Lindberg, E., Travaglino, E., Samuelsson, J., Hast, R., Nilsson, L., Cazzola, M., Invernizzi, R., Grandien, A., Zhivotovsky, B., & Fadeel, B. (2013)

The Effects of Mitochondrial Ferritin Expression in Normal and Sideroblastic Erythropoiesis.

Porta, M. G. D., Rosti, V., Gallì, A., Travaglino, E., Santambrogio, P., Marseglia, C., Matti, V., Malcovati, L., Bergamaschi, G., Levi, S., et al. (2009) · Blood · doi:10.1182/blood.v114.22.736.736 · Cited by 2 · see citing works

P-41 Aberrant mitochondrial iron distribution and maturation arrest characterizes early erythroid precursors in low-risk myelodysplastic syndromes

Tehranchi, R., Invernizzi, R. W., Grandien, A., Zhivotovsky, B., Fadeel, B., Forsblom, A., Travaglino, E., Samuelsson, J., Cazzola, M., Wibom, R., et al. (2005) · Leukemia Research · doi:10.1016/s0145-2126(05)80105-5 · Cited by 1 · see citing works

Effects of mitochondrial ferritin overexpression in normal and sideroblastic erythroid progenitors

Invernizzi, R., Travaglino, E., Porta, M. G. D., Gallì, A., Malcovati, L., Rosti, V., Bergamaschi, G., Erba, B. G., Bellistri, F., Bastia, R., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12316 · Cited by 12 · see citing works